Orlistat and weight loss
- PMID: 9808019
- DOI: 10.1016/S0140-6736(05)61300-1
Orlistat and weight loss
Comment on
-
Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group.Lancet. 1998 Jul 18;352(9123):167-72. doi: 10.1016/s0140-6736(97)11509-4. Lancet. 1998. PMID: 9683204 Clinical Trial.
Similar articles
-
Influences of fat restriction and lipase inhibition on gastric emptying in obesity.Int J Obes (Lond). 2006 Aug;30(8):1203-10. doi: 10.1038/sj.ijo.0803255. Epub 2006 Feb 7. Int J Obes (Lond). 2006. PMID: 16462818 Clinical Trial.
-
[Drug treatment of obesity].Ugeskr Laeger. 2006 Jan 9;168(2):163-7. Ugeskr Laeger. 2006. PMID: 16403342 Review. Danish.
-
[Orlistat (Xenical)].Rev Med Brux. 1999 Jun;20(3):159-63. Rev Med Brux. 1999. PMID: 10429540 Review. French.
-
Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study.Am J Clin Nutr. 1999 Jun;69(6):1108-16. doi: 10.1093/ajcn/69.6.1108. Am J Clin Nutr. 1999. PMID: 10357727 Clinical Trial.
-
Flushing away the fat. Weight loss during trials of orlistat was significant, but over half was due to diet.BMJ. 1998 Sep 26;317(7162):830-1. doi: 10.1136/bmj.317.7162.830. BMJ. 1998. PMID: 9748171 Free PMC article. No abstract available.
Cited by
-
Orlistat for the long-term management of obesity.Curr Gastroenterol Rep. 1999 Aug;1(4):316-8. doi: 10.1007/s11894-999-0115-2. Curr Gastroenterol Rep. 1999. PMID: 10980966 Review. No abstract available.
-
Orlistat, a new lipase inhibitor for the management of obesity.Pharmacotherapy. 2000 Mar;20(3):270-9. doi: 10.1592/phco.20.4.270.34882. Pharmacotherapy. 2000. PMID: 10730683 Free PMC article. Review.
-
Orlistat: a review of its use in the management of obesity.Drugs. 1999 Oct;58(4):743-60. doi: 10.2165/00003495-199958040-00015. Drugs. 1999. PMID: 10551441 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical